Similar articles

• The human melanocyte system as a model for studies on tumor progression.

  Valyi-Nagy I, Rodeck U, Kath R, Mancianti ML, Clark WH, Herlyn M. Valyi-Nagy I, et al. Basic Life Sci. 1991;57:315-26; discussion 326-8. doi: 10.1007/978-1-4684-5994-4_26. Basic Life Sci. 1991. PMID: 1814292 Review. No abstract available.
• Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study.

  Loir B, Pérez Sánchez C, Ghanem G, Lozano JA, García-Borrón JC, Jiménez-Cervantes C. Loir B, et al. Cell Mol Biol (Noisy-le-grand). 1999 Nov;45(7):1083-92. Cell Mol Biol (Noisy-le-grand). 1999. PMID: 10644013
• Lack of evidence of Ki-ras codon 12 mutations in melanocytic lesions.

  Albino AP, Nanus DM, Davis ML, McNutt NS. Albino AP, et al. J Cutan Pathol. 1991 Aug;18(4):273-8. doi: 10.1111/j.1600-0560.1991.tb01235.x. J Cutan Pathol. 1991. PMID: 1939786
• Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.

  Albino AP, Nanus DM, Mentle IR, Cordon-Cardo C, McNutt NS, Bressler J, Andreeff M. Albino AP, et al. Oncogene. 1989 Nov;4(11):1363-74. Oncogene. 1989. PMID: 2682463
• Morphometry of melanocytic skin lesions--verifications or vexations? A review of a group experience.

  Williams RA. Williams RA. Pathologica. 1998 Apr;90(2):183-5. Pathologica. 1998. PMID: 9619064 Review. No abstract available.